Sanchez AM et al. |
The molecular connections between the cannabinoid system and endometriosis. |
2012 |
Mol. Hum. Reprod. |
pmid:22923487
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Maccarrone M et al. |
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. |
2002 |
Mol. Hum. Reprod. |
pmid:11818522
|
Felder CC et al. |
Cannabinoids biology: the search for new therapeutic targets. |
2006 |
Mol. Interv. |
pmid:16809476
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|
Luchicchi A and Pistis M |
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. |
2012 |
Mol. Neurobiol. |
pmid:22801993
|
Kim SR et al. |
Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity. |
2007 |
Mol. Neurobiol. |
pmid:17917113
|
Zhang X et al. |
Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives. |
2012 |
Mol. Pharmacol. |
pmid:22328719
|
Snider NT et al. |
A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. |
2009 |
Mol. Pharmacol. |
pmid:19171674
|
Spivak CE et al. |
The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. |
2007 |
Mol. Pharmacol. |
pmid:17628012
|
Yates ML and Barker EL |
Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. |
2009 |
Mol. Pharmacol. |
pmid:19389920
|
Meuth SG et al. |
The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. |
2006 |
Mol. Pharmacol. |
pmid:16424077
|
Xiong W et al. |
Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. |
2008 |
Mol. Pharmacol. |
pmid:17993512
|
Mackie K et al. |
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. |
1993 |
Mol. Pharmacol. |
pmid:8371711
|
Sancho R et al. |
Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. |
2003 |
Mol. Pharmacol. |
pmid:12527815
|
Randall MD |
A new endothelial target for cannabinoids. |
2003 |
Mol. Pharmacol. |
pmid:12606752
|
Pan X et al. |
Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. |
1996 |
Mol. Pharmacol. |
pmid:8609900
|
McFarland MJ et al. |
RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. |
2008 |
Mol. Pharmacol. |
pmid:18436710
|
Hegde VL et al. |
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. |
2008 |
Mol. Pharmacol. |
pmid:18388242
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Felder CC et al. |
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. |
1995 |
Mol. Pharmacol. |
pmid:7565624
|
Moreno-Galindo EG et al. |
Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide. |
2010 |
Mol. Pharmacol. |
pmid:20133392
|
Hejazi N et al. |
Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. |
2006 |
Mol. Pharmacol. |
pmid:16332990
|
Lizanecz E et al. |
Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. |
2006 |
Mol. Pharmacol. |
pmid:16338989
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Day TA et al. |
Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. |
2001 |
Mol. Pharmacol. |
pmid:11353795
|
Theile JW and Cummins TR |
Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide. |
2011 |
Mol. Pharmacol. |
pmid:21788423
|
Breivogel CS et al. |
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. |
2001 |
Mol. Pharmacol. |
pmid:11408610
|
Priller J et al. |
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. |
1995 |
Mol. Pharmacol. |
pmid:7651362
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Andersson DA et al. |
Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. |
2002 |
Mol. Pharmacol. |
pmid:12181448
|
Neumeister A et al. |
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. |
2013 |
Mol. Psychiatry |
pmid:23670490
|
Gunduz-Cinar O et al. |
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. |
2013 |
Mol. Psychiatry |
pmid:22688188
|
Schuel H et al. |
Evidence that anandamide-signaling regulates human sperm functions required for fertilization. |
2002 |
Mol. Reprod. Dev. |
pmid:12237954
|
Paria BC et al. |
The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. |
1996 |
Mol. Reprod. Dev. |
pmid:8914076
|
Muccioli GG et al. |
The endocannabinoid system links gut microbiota to adipogenesis. |
2010 |
Mol. Syst. Biol. |
pmid:20664638
|
Pisani V et al. |
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients. |
2010 |
Mov. Disord. |
pmid:20461809
|
Pryce G et al. |
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. |
2013 |
Mult. Scler. |
pmid:23625705
|
Pastuhov SI et al. |
Endocannabinoid-Goα signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqα-PKC-JNK signalling. |
2012 |
Nat Commun |
pmid:23072806
|
Alpár A et al. |
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. |
2014 |
Nat Commun |
pmid:25030704
|
Mechoulam R and Ben-Shabat S |
From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. |
1999 |
Nat Prod Rep |
pmid:10331283
|
Nomura DK et al. |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
2008 |
Nat. Chem. Biol. |
pmid:18438404
|
Long JZ et al. |
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. |
2009 |
Nat. Chem. Biol. |
pmid:19029917
|
Voets T et al. |
Sensing with TRP channels. |
2005 |
Nat. Chem. Biol. |
pmid:16408004
|
Fields HL and Meng ID |
Watching the pot boil. |
1998 |
Nat. Med. |
pmid:9734389
|
Stock K et al. |
Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. |
2012 |
Nat. Med. |
pmid:22820645
|
Piomelli D |
THC: moderation during implantation. |
2004 |
Nat. Med. |
pmid:14702623
|
Kathuria S et al. |
Modulation of anxiety through blockade of anandamide hydrolysis. |
2003 |
Nat. Med. |
pmid:12461523
|
Jourdan T et al. |
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. |
2013 |
Nat. Med. |
pmid:23955712
|
Bátkai S et al. |
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. |
2001 |
Nat. Med. |
pmid:11433348
|